Celebrating 13 Years of Nonprofit Independence
Mending the Tattered Safety Net of the FDA

Mending the Tattered Safety Net of the FDA

Wednesday, September 24, 2025 . 8:00 am 60 min

Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In this webinar, experts reveal why the system is failing and the steps needed to drive real change in the generic drug marketplace.

Featuring

– Peter Baker, President, Live Oak Quality Assurance and Former FDA Inspector
– Rosemary Gibson, Author, China Rx: Exposing the Risks of America’s Dependence on China for Medicine
– John Gray, PhD, Dean’s Distinguished Professor, Department of Operations and Business Analytics, Ohio State University
– Suzanne Robotti, Founder and President, MedShadow Foundation

Investigating Generic Drugs is a webinar series for everyone who takes or prescribes medicine. Join this urgent public discussion with patients, doctors, pharmacists, researchers, and journalists to examine and improve generic drug safety.

Related Content

How Poor Quality Generic Drugs Cause Harm

If you feel like your generic drugs aren’t working, you may be right. Generics don’t alway...

Are Any of Us Safe from Faulty Generics?

Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates ...

What is unbiased drug-safety journalism worth to you?

We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.

Comments

No comments yet. Be the first to comment!